My Companies
Notification
Account
Board approved proposed acquisitions of 51% stakes in Matrix Labs Diagnocare, with FY25 turnover of ₹171.3 crore, and Matrix Labs, with ₹8.9 crore turnover, for aggregate share-swap consideration of ₹39.5 crore. It will issue 7.15 lakh shares at ₹553 each, subject to approvals. Context: internal-audit coverage has been restored.
One Global Service Provider Approves ₹39.54 Crore Matrix Labs Acquisition
One Global Service Provider Approves ₹39.54 Crore Matrix Labs Acquisition
One Global Service Provider Approves ₹39.54 Crore Diagnostics Acquisition
One Global Service Provider Schedules Board Meeting To Consider Preferential Issue